HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of germanium-132 on low-density lipoprotein oxidation and atherosclerosis in Kurosawa and Kusanagi hypercholesterolemic rabbits.

Abstract
Germanium-132 (Ge-132) was given at 200 mg/kg of body weight to 8-week-old Kurosawa and Kusanagi hypercholesterolemic (KHC) rabbits. Thirty-six weeks later, the susceptibility of plasma low-density lipoprotein to oxidation and the morphology of atherosclerosis in the aorta and coronary artery were investigated. Treatment with Ge-132 resulted in decreases in the oxidation rate and in the formation rate of thiobarbituric acid-reactive substances following copper-induced oxidation of LDL. Ge-132 is suggested to possess antioxidative properties, but this did not lead to any attenuation of atherosclerotic progression in the KHC rabbits.
AuthorsY Wakabayashi
JournalBioscience, biotechnology, and biochemistry (Biosci Biotechnol Biochem) Vol. 65 Issue 8 Pg. 1893-6 (Aug 2001) ISSN: 0916-8451 [Print] England
PMID11577738 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticholesteremic Agents
  • Lipoproteins, LDL
  • Organometallic Compounds
  • Propionates
  • Thiobarbituric Acid Reactive Substances
  • Germanium
  • propagermanium
Topics
  • Aging (pathology)
  • Animals
  • Anticholesteremic Agents (pharmacology)
  • Aorta, Thoracic (pathology)
  • Arteriosclerosis (blood)
  • Female
  • Germanium
  • Hypercholesterolemia (blood, pathology)
  • Kinetics
  • Lipoproteins, LDL (blood)
  • Organometallic Compounds (pharmacology)
  • Oxidation-Reduction
  • Oxidative Stress
  • Propionates
  • Rabbits
  • Thiobarbituric Acid Reactive Substances (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: